Strides Pharma Science Ltd
BSE: 532531
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 582.65-3.8% | 605.74+9.4% | 553.63+6.0% | 522.15+4.7% | 498.62-10.3% | 555.96+0.9% | 550.92-9.7% | 609.96 |
| Other Income | 1.48-62.8% | 3.97-96.2% | 103.24+632.6% | 14.09+701.6% | 1.76-85.5% | 12.12+399.3% | 2.43-89.7% | 23.55 |
| Total Income | 584.12-4.2% | 609.71-7.2% | 656.88+22.5% | 536.24+7.2% | 500.37-11.9% | 568.08+2.7% | 553.35-12.7% | 633.50 |
| EXPENSES | ||||||||
| Expenditure | 575.77-1.3% | 583.20+11.7% | 522.07+2.2% | 510.86+5.6% | 483.97-10.3% | 539.76+1.5% | 531.95-14.1% | 619.06 |
| Tax | 11.83+16.5% | 10.15-21.3% | 12.91+294.0% | -6.65-317.7% | 3.06-74.9% | 12.20+89.4% | 6.44+634.9% | 0.88 |
| PROFIT | ||||||||
| PBT | 84.76+219.7% | 26.51-80.3% | 134.80+431.0% | 25.39+54.8% | 16.40-42.1% | 28.32+32.5% | 21.38+48.1% | 14.43 |
| Net Profit | 72.93+346.0% | 16.35-86.6% | 121.89+280.4% | 32.04+140.1% | 13.35-17.2% | 16.13+8.0% | 14.94-2.4% | 15.31 |
| KEY METRICS | ||||||||
| OPM % | 23.60%+11.32pp | 12.28%-2.39pp | 14.67%+2.75pp | 11.92%-1.56pp | 13.48%+1.26pp | 12.22%+18.79pp | -6.57%+6.75pp | -13.32% |
| NPM % | 12.49%+9.81pp | 2.68%-15.88pp | 18.56%+12.59pp | 5.97%+3.30pp | 2.67%-0.17pp | 2.84%+0.14pp | 2.70%+0.28pp | 2.42% |
| EPS | 7.91+346.9% | 1.77-86.6% | 13.22+279.9% | 3.48+140.0% | 1.45-17.1% | 1.75+8.0% | 1.62-2.4% | 1.66 |
Corporate Events
Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
The 35th Annual General Meeting (AGM) of the Company is sche…
BSE Filing ↗Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
The Board of Directors of Strides Pharma Science Limited app…
BSE Filing ↗Board Meeting
The Board of Directors meeting was held on May 18, 2026. Th…
BSE Filing ↗Board Meeting
consider and approve the un-audited financial results (stand…
BSE Filing ↗Board Meeting
Consider and approve the un-audited financial results (stand…
BSE Filing ↗Board Meeting
Consider and approve Announcement of Board, consider and app…
BSE Filing ↗Board Meeting
To consider and approve the audited financial results (stand…
BSE Filing ↗Board Meeting
Consider and approve un-audited financial results for the qu…
BSE Filing ↗Board Meeting
Consideration of proposal to combine CDMO interests
BSE Filing ↗